Sisram Medical prices $125m IPO low
Sisram Medical, a subsidiary of Chinese conglomerate Fosun International, has raised HK$978.6m ($125m) from its spin off in Hong Kong, pricing the IPO at the bottom of guidance.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: